RT @doctorRBC: Great start to #ACR21 and great recap of the year in rheumatology. Positive data on tofacitinib and AS b
Tweet Content
Great start to #ACR21 and great recap of the year in rheumatology.
Positive data on tofacitinib and AS but still pending approval.
Where would JAKinibs be in your AS treatment algorithm?🤔
@RheumNow https://t.co/cs8U33355A
Show on Archive Page
On
Display in Search Results
On
PDQ
Off